Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FZ4HZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,423
Award facts
- Contract value 100% obligated
- $46,423.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $46,423.18 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on October 31, 2025. This firm fixed price contract, with an ultimate completion date of November 3, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this competitive award.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across the military and veteran healthcare systems. Dupixent is a biologic medication primarily indicated for eczema, asthma, and related inflammatory conditions, and its procurement through DLA reflects the Department of Defense's need to support medical treatment requirements across military healthcare infrastructure. The award demonstrates AmerisourceBergen's capability to fulfill specialized pharmaceutical supply requirements through its prime vendor relationship with DLA Troop Support Medical, which enables the company to deliver a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FZ4HZ?
SPE2DR26FZ4HZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DR26FZ4HZ worth?
The government has obligated $46,423 on SPE2DR26FZ4HZ.
Is contract SPE2DR26FZ4HZ an order under another contract?
Yes. SPE2DR26FZ4HZ is a delivery order under SPE2DR25D1050, an indefinite delivery contract.
Was contract SPE2DR26FZ4HZ competed?
The extent of competition for SPE2DR26FZ4HZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award